Dr. Chopra advocates for weight-loss drugs and interventions to combat obesity and sarcopenia, supporting both increased lifespan and healthspan. He emphasizes that these drugs, used responsibly with lifestyle changes, improve health, independence, and quality of life.
View More Here’s Why This Harvard Doctor Backs Weight-Loss Drugs
Non-alcoholic fatty liver disease (NAFLD) is rising, linked to poor diet, obesity, and sedentary lifestyles, not just alcohol. It often lacks early symptoms but can lead to severe liver damage. Prevention involves dietary changes, exercise, and even modest weight loss. Awareness is crucial.
View More Harvard Doctor On Why Fatty Liver Disease Is Dangerous Than Alcohol
NEW DELHI: Parliament today witnessed an impassioned plea by Member of Parliament Naveen Jindal, who highlighted the growing health dangers associated with industrial seed oils…
View More Naveen Jindal Seeks Tougher Food Laws for a Healthier India
The recent Lancet study revealing that Indians account for a staggering 25% of the world’s adult diabetes cases is a wake-up call of urgent proportions.…
View More Addressing India’s diabetes crisis: Call for comprehensive action
The study also revealed that India ranked 180th among 197 countries for the prevalence of obesity in men, and 182nd for women in 2022.
View More Lancet study reveals alarming rise of obesity in India